Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
featured
Published in COVID-19 and
1 other channel

Journal Scan / Research · December 13, 2023

Outcomes of Nirmatrelvir/Ritonavir Use in Pregnant Women With SARS-CoV-2 Omicron Infection

Nature Medicine

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Emmett Kistler MD

Nature Medicine
Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation
Nat. Med. 2023 Nov 01;[EPub Ahead of Print], CKH Wong, KTK Lau, MSH Chung, ICH Au, KW Cheung, EHY Lau, Y Daoud, BJ Cowling, GM Leung

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated